Drug Discovery and Development Overview
EPPIC Global (Digital)
October 17, 2020
twoXAR Pharmaceuticals SVP Nonclinical R&D & Chemistry Anjali Pandey moderates a panel including twoXAR CEO Andrew Radin, along with representatives from Recursion Pharma, ATOM Consortium, and NuMedii.
MIT ILP (Digital)
October 16, 2020
twoXAR Pharmaceuticals CEO Andrew Radin presents on the company's capabilities in discovering first-in-class small molecules for oncology and more using AI.
Johnson & Johnson Innovaion | JLabs Panel (Digital)
October 1, 2020
twoXAR Pharmaceuticals CEO Andrew A. Radin presents and joins the JLabs Panel to discuss how biology startups can partner with AI companies.